H.R. 7693 (119th)Legislative Design
To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.
Health|Health
Current stageCommittee
Referred to the House Committee on Energy and Commerce.
Introduced
Committee
Floor
President
Law
Legislative design
How complete and executable the bill text feels.
iThis page explains why each dimension scored the way it did, and which parts of implementation are explicit versus left to future interpretation.
No legislative design analysis yet for this bill.